Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yohimbine for Rapid Antidepressant Effects in Major Depression
NCT00078715Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Mar 2004
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yohimbine in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Mar 2004; status: completed.
02
Drugs
yohimbine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00078715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078715.